Difference between revisions of "DSC MRI Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
(Profile Development)
(DSC MRI Meetings)
Line 12: Line 12:
 
==DSC MRI Meetings==
 
==DSC MRI Meetings==
 
'''Recent Approved call summaries:'''
 
'''Recent Approved call summaries:'''
<br />Note: The last meeting of this group was held on May 8, 2019; notes are posted after they are approved by the DSC-MRI BC during the following t-con
+
<br />Note: The last meeting of this group was held on September 9, 2020; notes are posted after they are approved by the DSC-MRI BC during the following t-con
  
 
*[[Media:2020_07-08_QIBA_DSC-MRI_BC_Call_Summary-FINAL.pdf|July 8, 2020]]
 
*[[Media:2020_07-08_QIBA_DSC-MRI_BC_Call_Summary-FINAL.pdf|July 8, 2020]]
Line 21: Line 21:
  
 
* Earlier materials can be found on the [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]] page
 
* Earlier materials can be found on the [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]] page
 
  
 
==Profile Development==
 
==Profile Development==

Revision as of 23:25, 29 September 2020

Co-chairs: Bradley Erickson, MD, PhD; Ona Wu, PhD
RSNA Staff Support: Susan Stanfa


Project Snapshot

Develop a quantitative imaging profile for Dynamic Susceptibility Contrast MRI.


DSC MRI Meetings

Recent Approved call summaries:
Note: The last meeting of this group was held on September 9, 2020; notes are posted after they are approved by the DSC-MRI BC during the following t-con

DSC-MRI Call Summaries Archive

Profile Development

Historical Background - Formation of the Group

Reference Materials

QIBA Funded Projects

Round 5

Original Proposal to the QIBA Steering Committee

Round 6